Firefly Neuroscience, Inc.
AIFF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 29.8% | 595.3% | -18.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 37.6% | 91.6% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $1 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $3 | $2 | $2 | $3 |
| Operating Income | -$3 | -$2 | -$2 | -$3 |
| % Margin | -684.5% | -546.5% | -4,802.3% | -6,483% |
| Other Income/Exp. Net | $0 | -$0 | -$11 | -$0 |
| Pre-Tax Income | -$3 | -$2 | -$13 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$2 | -$13 | -$4 |
| % Margin | -680.2% | -613% | -30,069.8% | -7,141.5% |
| EPS | -0.2 | -0.14 | -1.74 | -0.45 |
| % Growth | -42.9% | 92% | -286.7% | – |
| EPS Diluted | -0.2 | -0.14 | -1.74 | -0.45 |
| Weighted Avg Shares Out | 13 | 13 | 10 | 8 |
| Weighted Avg Shares Out Dil | 13 | 13 | 10 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$13 | -$3 |
| % Margin | -619.3% | -592.3% | -29,727.9% | -4,826.4% |